Oxytocin and cortisol concentrations in adults with and without autism spectrum disorder in response to physical exercise.

Autism spectrum disorder Cortisol Oxytocin Stress

Journal

Comprehensive psychoneuroendocrinology
ISSN: 2666-4976
Titre abrégé: Compr Psychoneuroendocrinol
Pays: England
ID NLM: 101774169

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 04 12 2020
accepted: 05 01 2021
entrez: 27 6 2022
pubmed: 11 1 2021
medline: 11 1 2021
Statut: epublish

Résumé

Autism spectrum disorder (ASD) is a neurodevelopmental disorder, whose core symptoms consist of deficits in social interaction and communication as well as restricted and repetitive behavior. Brain oxytocin (OXT) has been associated with various prosocial behaviors, and might, therefore, be involved in the pathogenesis of disorders associated with socio-emotional dysfunctions such as ASD. However, significant associations between central and peripheral OXT levels may only be present in response to physiological or stressful stimuli but were not shown under baseline conditions. In this study, we, therefore, investigated salivary and plasma OXT in response to physical exercise in adults with ASD (

Identifiants

pubmed: 35754449
doi: 10.1016/j.cpnec.2021.100027
pii: S2666-4976(21)00001-1
pmc: PMC9216704
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100027

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

None.

Références

Trends Neurosci. 2012 Nov;35(11):649-59
pubmed: 22974560
J Autism Dev Disord. 2004 Apr;34(2):163-75
pubmed: 15162935
Neurosci Biobehav Rev. 2017 Jul;78:117-124
pubmed: 28442403
Mol Autism. 2010 Sep 27;1(1):13
pubmed: 20875126
Autism Res. 2019 Aug;12(8):1156-1161
pubmed: 31132232
Psychoneuroendocrinology. 2018 Feb;88:61-69
pubmed: 29175721
Brain Behav Immun. 2003 Oct;17(5):373-83
pubmed: 12946659
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4389-94
pubmed: 20160081
Biol Psychiatry. 2016 Feb 1;79(3):213-21
pubmed: 26208744
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jul;4(7):655-663
pubmed: 30846366
Horm Behav. 2018 Sep;105:157-165
pubmed: 30165062
Dev Psychopathol. 2009 Winter;21(1):69-85
pubmed: 19144223
Psychoneuroendocrinology. 2019 Sep;107:225-231
pubmed: 31163380
Psychoneuroendocrinology. 2015 Dec;62:381-8
pubmed: 26385109
J Neurosci Methods. 2018 Jan 01;293:67-76
pubmed: 28865986
Res Dev Disabil. 2006 May-Jun;27(3):254-89
pubmed: 16002261
Biol Psychiatry. 1998 Feb 15;43(4):270-7
pubmed: 9513736
Atten Defic Hyperact Disord. 2014 Sep;6(3):231-9
pubmed: 24989441
Neurosci Biobehav Rev. 2013 Sep;37(8):1485-92
pubmed: 23665533
Psychoneuroendocrinology. 2004 Jan;29(1):83-98
pubmed: 14575731
Psychoneuroendocrinology. 2016 Dec;74:111-120
pubmed: 27608360
Autism. 2012 Mar;16(2):123-38
pubmed: 22087042
Lancet Psychiatry. 2015 Nov;2(11):1013-27
pubmed: 26544750
Dev Psychopathol. 2009 Winter;21(1):47-68
pubmed: 19144222
Psychoneuroendocrinology. 2005 Jan;30(1):80-91
pubmed: 15358445
Psychoneuroendocrinology. 2014 Feb;40:159-69
pubmed: 24485488
Psychoneuroendocrinology. 2004 Sep;29(8):983-92
pubmed: 15219648
Autism. 2009 May;13(3):215-28
pubmed: 19369385
Autism Res. 2013 Apr;6(2):91-102
pubmed: 23413037
Psychosom Med. 2013 Nov-Dec;75(9):832-40
pubmed: 24184845
Contemp Clin Trials Commun. 2018 Aug 07;11:156-164
pubmed: 30112460
J Psychosom Res. 1994 Jan;38(1):23-32
pubmed: 8126686
Endocr Rev. 2017 Feb 1;38(1):3-45
pubmed: 27749086
Adv Neurobiol. 2020;24:97-141
pubmed: 32006358
J Autism Dev Disord. 2006 Oct;36(7):891-9
pubmed: 16865550
Psychophysiology. 2010 Jul 1;47(4):625-32
pubmed: 20102537
Eur Psychiatry. 2019 Jan;55:80-89
pubmed: 30399531
Med Sci Sports Exerc. 1995 Jun;27(6):863-7
pubmed: 7658947
Biol Psychiatry. 2001 Oct 15;50(8):609-13
pubmed: 11690596
Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):150-76
pubmed: 15589267
J Autism Dev Disord. 2014 Aug;44(8):1996-2012
pubmed: 24590409
Psychoneuroendocrinology. 2013 May;38(5):694-701
pubmed: 22999263
J Neurodev Disord. 2016 Aug 18;8:32
pubmed: 27540420
Eur J Endocrinol. 2008 Dec;159(6):729-37
pubmed: 18794210
BMC Psychiatry. 2013 Apr 29;13:124
pubmed: 23627666
Autism. 2020 Nov;24(8):2046-2056
pubmed: 32662285
Psychol Bull. 2004 May;130(3):355-91
pubmed: 15122924
Res Autism Spectr Disord. 2012 Winter;6(1):177-183
pubmed: 22081773
Dev Psychobiol. 2009 May;51(4):367-73
pubmed: 19365797
Mol Psychiatry. 2015 Sep;20(9):1085-90
pubmed: 25349162
Psychoneuroendocrinology. 1997 Feb;22(2):89-105
pubmed: 9149331
Psychol Med. 2001 Aug;31(6):1025-35
pubmed: 11513370
J Neuroendocrinol. 2016 Oct;28(10):
pubmed: 27467712
Mol Autism. 2012 Nov 17;3(1):13
pubmed: 23158965
Psychoneuroendocrinology. 2010 Sep;35(8):1133-41
pubmed: 20153585
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Neurobiol Stress. 2016 Nov 12;6:113-126
pubmed: 28229114
Physiol Rev. 2018 Jul 1;98(3):1805-1908
pubmed: 29897293
J Autism Dev Disord. 2013 Oct;43(10):2405-17
pubmed: 23430177
Front Neuroendocrinol. 2016 Oct;43:19-27
pubmed: 27836673
Trends Neurosci. 1997 Feb;20(2):78-84
pubmed: 9023876
J Psychiatry Neurosci. 2008 May;33(3):227-34
pubmed: 18592041
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12258-63
pubmed: 25092315
Eur Neuropsychopharmacol. 2020 Jan;30:87-101
pubmed: 30201120
Psychoneuroendocrinology. 2017 Mar;77:165-174
pubmed: 28064086
Neurosciences (Riyadh). 2005 Jan;10(1):47-50
pubmed: 22473184
Prog Brain Res. 2002;139:147-62
pubmed: 12436933
Eur J Appl Physiol. 2000 May;82(1-2):112-6
pubmed: 10879451
Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):132-49
pubmed: 15589266
J Autism Dev Disord. 1992 Sep;22(3):449-51
pubmed: 1400106

Auteurs

L Albantakis (L)

Max Planck Institute of Psychiatry - Independent Max Planck Research Group for Social Neuroscience, Kraepelinstr. 2-10, 80804, Munich, Germany.
International Max Planck Research School for Translational Psychiatry, Kraepelinstr. 2-10, 80804, Munich, Germany.

M-L Brandi (ML)

Max Planck Institute of Psychiatry - Independent Max Planck Research Group for Social Neuroscience, Kraepelinstr. 2-10, 80804, Munich, Germany.

T Brückl (T)

Max Planck Institute of Psychiatry - Translational Research in Psychiatry, Kraepelinstr. 2-10, 80804, Munich, Germany.

D Gebert (D)

Neurological Specialty Hospital for Movement Disorders/Parkinson's Disease, Straße Nach Fichtenwalde 16, 14547, Beelitz, Germany.

M K Auer (MK)

Medizinische Klinik and Poliklinik IV, LMU Klinikum, Ziemssenstr. 1, 80336, Munich, Germany.

A Kopczak (A)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Feodor-Lynen-Straße 17, 81377, Munich, Germany.

G K Stalla (GK)

Medizinische Klinik and Poliklinik IV, LMU Klinikum, Ziemssenstr. 1, 80336, Munich, Germany.
Medicover Neuroendokrinologie, Orleansplatz 3, 81667, Munich, Germany.

I D Neumann (ID)

Department of Behavioural and Molecular Neurobiology, University of Regensburg, Universitätsstr. 31, 93053, Regensburg, Germany.

L Schilbach (L)

Max Planck Institute of Psychiatry - Independent Max Planck Research Group for Social Neuroscience, Kraepelinstr. 2-10, 80804, Munich, Germany.
International Max Planck Research School for Translational Psychiatry, Kraepelinstr. 2-10, 80804, Munich, Germany.
Ludwig-Maximilians-Universität München, Geschwister-Scholl-Platz 1, 80539, Munich, Germany.
Graduate School of Systemic Neurosciences, LMU Munich, Großhaderner Str. 2, 82152 Planegg, Germany.

Classifications MeSH